Zhongke Borui, a company incubated by the Institute of Automation under the Chinese Academy of Sciences, is dedicated to translating cutting-edge brain science technologies into clinical applications. Covering the entire medical device chain and upholding a brain-centric R&D philosophy, the company recently secured a B+ round of financing worth hundreds of millions of yuan within the same year, with joint investment from Houji Capital and Muhua Sci-Tech Innovation. This marks the second major financing milestone following its tens-of-millions-yuan B round in March 2026, with Kaicheng Capital serving as the long-term exclusive financial advisor. The proceeds from this round will be used to deepen the business layout, expand the talent team, accelerate the development of brain-computer interface products, scale up production capacity, and broaden global distribution channels. Leaders from all participating parties expressed confidence in the company's technological and industrialization capabilities, and affirmed their commitment to advancing the independent controllability and industrial development of domestically produced brain-computer interfaces.
